Record Details

Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models

ScholarsArchive at Oregon State University

Field Value
Title Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models
Names Chew, Ti Weng (creator)
Liu, Xing Jun (creator)
Liu, Lihui (creator)
Spitsbergen, Jan M. (creator)
Gong, Zhiyuan (creator)
Low, Boon Chuan (creator)
Date Issued 2014-05-22 (iso8601)
Note This is an author's peer-reviewed final manuscript, as accepted by the publisher. The published article is copyrighted by Macmillan Publishers Limited for the Nature Publishing Group and can be found at: http://www.nature.com/onc/index.html.
Abstract RAS and Rho small GTPases are key molecular switches that control cell dynamics, cell
growth and tissue development through their distinct signaling pathways. While much has been
learnt about their individual functions in both cell and animal models, the physiological and
pathophysiological consequences of their signaling crosstalk in multi-cellular context in vivo
remain largely unknown, especially in liver development and liver tumorigenesis. Furthermore,
the roles of RhoA in RAS-mediated transformation and their crosstalk in vitro remain highly
controversial. When challenged with carcinogens, zebrafish developed liver cancer that
resembles the human liver cancer both molecularly and histopathologically. Capitalizing on the
growing importance and relevance of zebrafish (Danio rerio) as an alternate cancer model, we
have generated liver-specific, Tet-on inducible transgenic lines expressing oncogenic Kras[superscript G12V],
RhoA, constitutively-active RhoA[superscript G14V] or dominant-negative RhoA[superscript T19N]. Double transgenic lines
expressing Kras[superscript G12V] with one of the three RhoA genes were also generated. Based on
quantitative bioimaging and molecular markers for genetic and signaling aberrations, we showed
that the induced expression of oncogenic Kras during early development led to liver enlargement
and hepatocyte proliferation, associated with elevated Erk phosphorylation, Akt2-p21Cip
expression and activation. Such an increase in liver size and Akt2 expression was augmented
by dominant-negative RhoA[superscript T19N], but was abrogated by the constitutive-active RhoA[superscript G14V].
Consequently, induced expression of the oncogenic Kras in adult transgenic fish led to the
development of hepatocellular carcinomas. Survival studies further revealed that the co-expression
of dominant-negative RhoA[superscript T19N] with oncogenic Kras increased the mortality rate
compared to the other single or double transgenic lines. This study represents the first in
vivo investigation of the previously unappreciated signaling crosstalk between Kras and RhoA in
regulating liver overgrowth and liver tumorigenesis. Our results also implicate that activating
Rho could be beneficial to suppress the Kras-induced liver malignancies.
Genre Article
Topic Hepatocellular carcinoma
Identifier Chew, T. W., Liu, X. J., Liu, L., Spitsbergen, J. M., Gong, Z., & Low, B. C. (2014). Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models. Oncogene, 33(21), 2717-2727. doi:10.1038/onc.2013.240

© Western Waters Digital Library - GWLA member projects - Designed by the J. Willard Marriott Library - Hosted by Oregon State University Libraries and Press